Operating profit before deduction of amortization: connectbiopharm.com (CNTB)
EBITDA analytics on the GURU.Markets terminal linear chart demonstrate the impact of ambitious research and a strong team of biochemists on the value of Connect Biopharma (CNTB), where the 0.00 mark indicates the profit level. Growth is based on the implementation of new immune modulation standards for allergists. The scaling of drug production is ensured through flexible partnerships with external contract manufacturing organizations.
Connect Biopharma Holdings Limited (CNTB) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
Debt to Equity Ratio Connect Biopharma|CNTB - Long-Term Debt to Capital|Current Liabilities to Capital Connect Biopharma Holdings|CNTB - Company Aggregate Debts|Debt to Book Value Connect Biopharma|CNTB - Company Long-Term Debt|Short-Term Debt Connect Biopharma|Immediate Liquidity Ratio connectbiopharm.com
- earnings and multiples data:
CNTB - Company Net Income|Net Profit Forecast Connect Biopharma|CNTB - P/E Multiple|Projected Price to Earnings Ratio Connect Biopharma Holdings|CNTB - PEG Multiple|Enterprise Value to EBITDA Ratio Connect Biopharma|CNTB - Operating profit before deduction of amortization|Earnings per share for the last four quarters Connect Biopharma|CNTB - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months connectbiopharm.com|CNTB - Earnings growth in current year|Net earnings per share growth forecast for next year Connect Biopharma
Summary company analytics:CNTB - Connect Biopharma
The scale of Connect Biopharma (CNTB) operations is determined by the balance between R&D expenditures and revenues from the Chinese market, a trend captured by the cash EBITDA dynamics. This metric isolates operating cash flow from the impact of taxes and interest, allowing investors to assess the real ability of the immunotherapy business to generate capital to maintain the sustainability of its drug pipeline.
Competitors of Connect Biopharma (CNTB)
Operating income before deduction of amortization argenx BVBA (ARGX)|BNTX - Profit before payment of interest, taxes and amortization|Abivax S.A. (ABVX) - Operating profit before deduction of amortization|ADMA Biologics, Inc. (ADMA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Protagonist Therapeutics, Inc.|Operating profit before deduction of amortization IMVT|Operating profit EBITDA Kiniksa Corp|Profit before payment of interest, taxes and amortization Grifols, S.A. (GRFS)|adaptivebiotech.com - Operating profit before amortization|Operating profit EBITDA CLDX (Celldex Therapeutics, Inc.)|Aurinia Pharmaceuticals Inc (AUPH) - Profit before interest, taxes and amortization|BioCryst Pharmaceuticals Inc - Operating profit EBITDA|Vera Corp (VERA) - Operating profit before deduction of amortization|Dianthus Therapeutics (DNTH) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization pharvaris.com (PHVS)|Profit before payment of interest, taxes and amortization AbCellera Biologics Inc.|Operating profit before amortization TRML (Tourmaline Bio Inc)|Profit before payment of interest, taxes and amortization Intrexon (PGEN)|Pharming Corp - Operating profit before amortization|Operating profit EBITDA NKTR (Nektar Therapeutics)|upstreambio.com (UPB) - Profit before interest, taxes and amortization|Zenas Biopharma - Operating profit EBITDA|Immunome Inc (IMNM) - Operating profit before deduction of amortization|GOSS (Gossamer Corp) - Operating profit before deduction of amortization|KALV: Company profit before taxes, interest and amortization|Operating profit before deduction of amortization SEPN|PVLA: Income before deduction of interest, taxes and amortization|Operating profit EBITDA SVRA|Profit before payment of interest, taxes and amortization RIGL (Rigel Pharma)|Operating profit EBITDA ANAB (AnaptysBio Corp)|Operating income before deduction of amortization Astria Corp (ATXS)|ENGN - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization RAPT Therapeutics Inc.|aerovatetx.com (JBIO) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization ACRS (Aclaris Therapeutics Inc.)|KYTX (Kyverna) - Operating profit EBITDA|TLSA: Income before deduction of interest, taxes and amortization|Operating profit EBITDA CABA|Operating profit EBITDA ventyxbio.com (VTYX)|Profit before payment of interest, taxes and amortization Theratechnologies THTX|Income before deduction of interest, taxes and amortization AVTX|ELDN - Profit before payment of interest, taxes and amortization|Agenus, Inc (AGEN) - Operating profit before deduction of amortization|CLYM: Operating profit EBITDA|Zura Bio Ltd (ZURA) - Operating profit EBITDA|ATYR (aTyr Pharma) - Operating profit EBITDA|Operating profit before deduction of amortization Adagene Corp (ADAG)|Profit before payment of interest, taxes and amortization ImageneBio Inc (IMA)|shattucklabs.com - Operating profit before amortization|Equillium - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization IMUX (Immunic Therapeutics)|Atara Biotherapeutics Inc - Operating profit EBITDA|IFRX: Profit before payment of interest, taxes and amortization|X4 Pharma (XFOR) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization ACET (Adicet Bio, Inc.)|CELU (Celularity Inc) - Operating profit EBITDA|INMB: Income before deduction of interest, taxes and amortization|Operating profit EBITDA BRNS|Operating profit EBITDA Kezar Life Sciences Inc. (KZR)|Profit before payment of interest, taxes and amortization SAB Biotherapeutics, Inc SABS|Income before deduction of interest, taxes and amortization AKTX|ENLV - Profit before payment of interest, taxes and amortization|Q32 Bio Inc. (QTTB) - Operating profit before deduction of amortization|GOVX: Operating profit EBITDA|Edesa Biotech Inc (EDSA) - Operating profit EBITDA|Operating profit before deduction of amortization IBIO|CARM: Income before deduction of interest, taxes and amortization|Operating profit EBITDA XTLB|Operating income before deduction of amortization boltbio.com|Profit before payment of interest, taxes and amortization HCW Biologics HCWB|APVO - Operating profit before deduction of amortization|AIM - Profit before payment of interest, taxes and amortization|Aditxt (ADTX) - Operating profit before deduction of amortization|GRI (GRI Bio, Inc.) - Operating profit before deduction of amortization|xortx.com (XRTX) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Vyome Holdings|Operating profit before amortization REVB (Revelation Biosciences Inc)|Operating profit EBITDA INDP|SCNI - Profit before interest, taxes and amortization|Operating profit EBITDA CALI (CalciMedica)|AFMD - Operating profit before deduction of amortization|ALLK - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization HOOKIPA Pharma Inc.|igmbio.com (IGMS) - Profit before payment of interest, taxes and amortization|Operating profit before amortization ITOS|Profit before payment of interest, taxes and amortization Ocean Biomedical, Inc.|Operating profit before amortization TCBP (tcbiopharm.com)|Operating profit EBITDA THRD
